INS and type 1 diabetes mellitus: In type 1 diabetes, there is often a ‘honeymoon period’ of partial clinical remission in the months after diagnosis, where newly diagnosed individuals often exhibit improved glycaemic control (HbAlc <48 mmol/mol [<6.5%]) and reduced insulin dose requirements (<0.5 U/kg) [70–72].